[MAYBANK] QoQ Cumulative Quarter Result on 31-Dec-2006 [#2]

Announcement Date
21-Feb-2007
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2007
Quarter
31-Dec-2006 [#2]
Profit Trend
QoQ- 139.32%
YoY- 4.13%
View:
Show?
Cumulative Result
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
Revenue 3,922,105 15,179,312 10,966,214 7,000,075 3,540,112 12,754,491 9,787,302 -45.61%
PBT 1,014,102 4,363,698 3,032,399 2,004,247 870,833 3,988,065 2,812,964 -49.31%
Tax -262,141 -1,110,827 -847,522 -589,829 -284,910 -1,153,481 -822,598 -53.31%
NP 751,961 3,252,871 2,184,877 1,414,418 585,923 2,834,584 1,990,366 -47.70%
-
NP to SH 735,429 3,178,372 2,125,566 1,360,955 568,681 2,772,418 1,946,394 -47.70%
-
Tax Rate 25.85% 25.46% 27.95% 29.43% 32.72% 28.92% 29.24% -
Total Cost 3,170,144 11,926,441 8,781,337 5,585,657 2,954,189 9,919,907 7,796,936 -45.08%
-
Net Worth 19,903,276 15,198,683 15,343,511 17,796,929 17,738,551 16,741,323 16,767,749 12.09%
Dividend
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
Div 680,952 3,079,071 1,534,351 1,527,371 - 3,203,035 1,879,792 -49.15%
Div Payout % 92.59% 96.88% 72.19% 112.23% - 115.53% 96.58% -
Equity
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
Net Worth 19,903,276 15,198,683 15,343,511 17,796,929 17,738,551 16,741,323 16,767,749 12.09%
NOSH 3,891,158 3,848,839 3,835,877 3,818,427 3,801,742 3,768,276 3,759,585 2.31%
Ratio Analysis
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
NP Margin 19.17% 21.43% 19.92% 20.21% 16.55% 22.22% 20.34% -
ROE 3.70% 20.91% 13.85% 7.65% 3.21% 16.56% 11.61% -
Per Share
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
RPS 100.80 394.39 285.89 183.32 93.12 338.47 260.33 -46.84%
EPS 18.90 66.07 44.33 35.64 14.96 73.57 51.77 -48.88%
DPS 17.50 80.00 40.00 40.00 0.00 85.00 50.00 -50.30%
NAPS 5.115 3.9489 4.00 4.6608 4.6659 4.4427 4.46 9.55%
Adjusted Per Share Value based on latest NOSH - 3,834,421
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
RPS 32.51 125.82 90.90 58.02 29.34 105.72 81.13 -45.61%
EPS 6.10 26.35 17.62 11.28 4.71 22.98 16.13 -47.67%
DPS 5.64 25.52 12.72 12.66 0.00 26.55 15.58 -49.17%
NAPS 1.6498 1.2598 1.2718 1.4752 1.4703 1.3877 1.3899 12.09%
Price Multiplier on Financial Quarter End Date
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
Date 28/09/07 29/06/07 30/03/07 29/12/06 29/09/06 30/06/06 31/03/06 -
Price 11.00 12.00 12.80 11.80 11.20 10.70 11.00 -
P/RPS 10.91 3.04 4.48 6.44 12.03 3.16 4.23 87.96%
P/EPS 58.20 14.53 23.10 33.11 74.87 14.54 21.25 95.63%
EY 1.72 6.88 4.33 3.02 1.34 6.88 4.71 -48.87%
DY 1.59 6.67 3.13 3.39 0.00 7.94 4.55 -50.35%
P/NAPS 2.15 3.04 3.20 2.53 2.40 2.41 2.47 -8.82%
Price Multiplier on Announcement Date
30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 31/03/06 CAGR
Date 15/11/07 29/08/07 11/05/07 21/02/07 14/11/06 24/08/06 15/05/06 -
Price 11.40 11.60 12.40 13.20 11.50 10.80 11.30 -
P/RPS 11.31 2.94 4.34 7.20 12.35 3.19 4.34 89.26%
P/EPS 60.32 14.05 22.38 37.04 76.88 14.68 21.83 96.79%
EY 1.66 7.12 4.47 2.70 1.30 6.81 4.58 -49.13%
DY 1.54 6.90 3.23 3.03 0.00 7.87 4.42 -50.45%
P/NAPS 2.23 2.94 3.10 2.83 2.46 2.43 2.53 -8.06%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment